Abiopharma

🔍 Hanson Kristopher (Executive)

Company: MapLight Therapeutics, Inc. (MPLT)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 7,730 shares of Voting Common Stock (Direct)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 153,553.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 31,395 shares of Employee Stock Option (right to buy) at $11.245 per share (Derivative)
  Date: 2026-08-17 | Code: A | Expires: 2036-08-16 | equity_swap_involved: 0 | shares_owned_after: 31,395.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
• F2: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
• F3: 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.